Sector ratings DexCom, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-25 EDT			5-day change	1st Jan Change
89.16 ^USD	-2.09%		-0.49%	+34.34%

08-24	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
DEXCOM, INC.	33.65B	BBB
ABBOTT LABORATORIES	201B	BBB
MEDTRONIC PLC	117B	BBB
CENCORA, INC.	62.6B	AA
HOYA CORPORATION	52.49B	AAA
BECTON, DICKINSON AND COMPANY	51.69B	A
MEDLINE INC.	31.27B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.52B	AA
TERUMO CORPORATION	24.05B	AA
STERIS PLC	23.05B	AAA	-
SARTORIUS STEDIM BIOTECH	22.06B	BBB
ZIMMER BIOMET HOLDINGS, INC.	19.12B	A
SOLVENTUM CORPORATION	15.59B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.74B	A
BAXTER INTERNATIONAL INC.	13.59B	A
ALIGN TECHNOLOGY, INC.	11.34B	A
GLOBUS MEDICAL, INC.	11.14B	CCC
REPLIGEN CORPORATION	10.25B	AA
BIO-RAD LABORATORIES, INC.	10.31B	BBB	-
INSULET CORPORATION	9.92B	A
Average	38B	A
Weighted average by Cap.		A